New Advances in Cytotoxicity Assay Workflows using the Celigo Imaging Cytometer

The Celigo Image Cytometer has been previously used for a wide range of immuno-oncology and immunotherapy studies, demonstrating the great utility of this instrument to assess the activity of cytotoxic immune cells against malignant cells of interest.

Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties

Sangivamycin is an unsuccessful anti-cancer drug candidate that has proven to be a potent inhibitor of multiple viruses. The authors of this study hypothesized that this compound would also be active against SARS-CoV-2.

Your cell counts will never be perfect – here’s why

“Biological variation” is an easy explanation to reach for when repeated measurements don’t match up very well. It is vague enough to excuse inconsistency in nearly any biological experiment, and in many cases, it is difficult to disprove.

By |2022-09-09T14:23:52+00:00September 9th, 2022|Categories: Accurate Cell Counting, Cell Counting Leadership, Latest News, Uncategorized|Tags: |0 Comments

Study finds a possible link between BCCIP and poor patient prognosis in lung adenocarcinoma

Starting with a bioinformatics approach using publicly available databases, the authors were able to confirm that tissues from patients with lung adenocarcinoma had increased expression of BCCIP and that high expression levels of BCCIP were correlated with poor patient prognosis.

T cell immunotherapy workflow improvements for clinical-grade manufacturing

Cell-based treatments are life-saving therapies with the potential to offer cures for cancers and other diseases.

Designing high-content tumor spheroid drug screening using high-throughput image cytometry

Solid tumor biology has become a critical step in accessing the potency of many cancer drugs. 3D spheroids and organoids can provide measurements such as size differences under drug conditions or metabolism and diffusion rates critical to drug development.

Repurposing immune cells to develop new therapies

For the development of new drugs and the advancement of new cell therapies, pharmaceutical companies have recurred to cytotoxicity assays as a quick way to assess the viability of cell lines in response to an external stimulus.

A rapid method to establish potential molecular targets for colorectal cancer progression

The development of targeted molecular therapies is an increasingly popular approach to combat and overcome the limitations of conventional treatments.

Identifying Downstream Candidates for Targeted Molecular Therapy

A fundamental understanding of the molecular mechanisms responsible for the development and progression of RCC will be pivotal in developing next-generation treatment protocols to improve patient outcomes.

Cell counting: A practical guide to evaluating cell counting methods

Because there is no certified reference material to determine cell concentration, ISO cell counting standards are a valuable tool for evaluating and selecting fit-for-purpose cell counting methods.

Go to Top